Comparison of MRI, EEG, EPs and ECD‐SPECT in Wilson's disease

Objectives – The purpose of this study is to evaluate the efficiency of a few methodologies in detecting anatomo‐functional brain abnormalities in patients with Wilson's disease. Materials and methods – Twenty‐three patients with Wilson's disease underwent almost simultaneously brain magnetic resonance imaging (MRI), computerized electroencephalography (EEG), multimodal evoked potentials (EPs) and ECD single photon computerized tomography (SPECT) evaluation. The clinical picture was of the neurologic type in 8 patients and of the hepatic type in 15. Results – MRI was abnormal in 7 patients with neurological manifestations. The EPs proved pathologic in 7 neurologically symptomatic patients and in 4 cases with hepatic form. These results agree with those reported in other case studies. The EEG records were abnormal only in 3 cases. Nevertheless, the most interesting finding of this study is the particular frequency (86%) of diffuse or focal decrease of ECD uptake shown by brain SPECT. Conclusion – We highlight the use of this interesting procedure in the therapeutic monitoring of this disease.

[1]  THE PATHOLOGY OF THE NERVOUS SYSTEM IN A CASE OF PROGRESSIVE LENTICULAR DEGENERATION , 1917 .

[2]  W. Spielmeyer Die histopathologische Zusammengehörigkeit der Wilsonschen Krankheit und der Pseudosklerose , 1920 .

[3]  A. Braunmühl Die Rinden-Markkomponente im anatomischen Bild der Wilson-Pseudosklerosegruppe , 1930 .

[4]  A. Wallgren,et al.  SOME ASPECTS OF HEPATOLENTICULAR DEGENERATION AND ITS PATHOGENESIS , 1934 .

[5]  I. Freiman,et al.  HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) FOLLOWING SPLENECTOMY; INTER-RELATIONSHIP OF THE RETICULO-ENDOTHELIAL AND CENTRAL NERVOUS SYSTEMS , 1941 .

[6]  N. W. Konowalow Histopathologie der hepatolentikulären Degeneration: II. Mitteilung. Histopathologie der Rindenerweichungen , 1941 .

[7]  I. Freiman,et al.  Progressive lenticular degeneration , 1942 .

[8]  R. Richter The pallial component in hepato-lenticular degeneration. , 1948, Journal of neuropathology and experimental neurology.

[9]  THE PALLIAL COMPONENT IN HEPATOLENTICULAR DEGENERATION , 1948 .

[10]  Unusual mental symptoms in a case of hepatolenticular degeneration. , 1950, Diseases of the nervous system.

[11]  Effect of dimercaprol (BAL) in hepatolenticular degeneration; report of a case, with clinical and electroencephalographic study. , 1953, A.M.A. archives of neurology and psychiatry.

[12]  J. Walshe Wilson's disease; new oral therapy. , 1956, The Lancet.

[13]  P. Loiseau,et al.  [Electroencephalogram in Wilson-Westphal-Strumpell disease]. , 1957, L'Encephale.

[14]  Dégénérescence hépato-lenticulaire. Étude anatomo-clinique, électroencéphalographique et biochimique à propos de trois cas dont deux jumeaux; pp. 445–460 , 1960 .

[15]  F. Kolb,et al.  Hepatolenticular degeneration. Clinical, biochemical and pathologic study of a patient with fulminant course aggravated by treatment with BAL and versenate. , 1960, The American journal of medicine.

[16]  The electroencephalogram in hepatolenticular degeneration (Wilson's disease). , 1962, Electroencephalography and clinical neurophysiology.

[17]  K. A. Kooi,et al.  The electroencephalogram in hepato-lenticular degeneration (Wilson's disease) , 1962 .

[18]  A GENETIC, BIOCHEMICAL AND CLINICAL STUDY OF WILSON'S DISEASE AMONG CHINESE IN TAIWAN. , 1963, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui.

[19]  S. Schulman,et al.  WILSON'S DISEASE: A CASE WITH ALMOST TOTAL LOSS OF CEREBRAL WHITE MATTER*,†,‡ , 1963 .

[20]  CLINICAL AND PATHOLOGICAL ASPECTS OF WILSON'S DISEASE IN CASES OF ONE AND THE SAME FAMILY. , 1965, The Tohoku journal of experimental medicine.

[21]  [Hepatocerebral degeneration (Wilson's disease). I. Pathogenesis, clinical aspects, electroencephalogram]. , 1965, Medizinische Klinik.

[22]  Richard H. Mattson,et al.  Seizures in Wilson's disease , 1967, Neurology.

[23]  Hereditary hepatolenticular degeneration (Wilson's disease). Report of the first case in Jamaica. , 1968, Tropical and geographical medicine.

[24]  EEG changes in Wilson's disease. , 1969, Electroencephalography and clinical neurophysiology.

[25]  An electroencephalographic and psychiatric study of 32 insane murderers. , 1969 .

[26]  Uncommon EEG findings in hepato-lenticular degeneration. , 1969, Electroencephalography and clinical neurophysiology.

[27]  S. Otsuki,et al.  A case of Wilson's disease with enormous cavity formation of cerebral white matter , 1972, Neurology.

[28]  Manifestations convulsives dans la maladie de Wilson , 1973 .

[29]  J. Walshe Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. , 1973, The Quarterly journal of medicine.

[30]  B. Westmoreland,et al.  Wilson's disease. Electroencephalographic and evoked potential studies. , 1974, Mayo Clinic proceedings.

[31]  A. Anzil,et al.  Ultrastructure of brain and nerve biopsy tissue in Wilson disease. , 1974, Archives of neurology.

[32]  T. Miyakawa,et al.  An autopsy case of the "demyelinating type" of Wilson's disease. , 1976, Acta neuropathologica.

[33]  T. Hoogenraad,et al.  Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). , 1979, European neurology.

[34]  N. Chu,et al.  Sensory evoked potentials in Wilson's disease. , 1986, Brain : a journal of neurology.

[35]  S. Nevsimalova,et al.  An EEG study of Wilson's disease. Findings in patients and heterozygous relatives. , 1986, Electroencephalography and clinical neurophysiology.

[36]  A. Young,et al.  Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. , 1987, Archives of neurology.

[37]  P. Sharp,et al.  Technetium-99m HMPAO imaging in patients with basal ganglia disease. , 1988, The British journal of radiology.

[38]  T. Dening,et al.  Wilson's disease and epilepsy. , 1988, Brain : a journal of neurology.

[39]  [Wilson's disease: demonstration of lesions of the cortex and white matter by MRI]. , 1988, Revue neurologique.

[40]  N. Chu Clinical, CT and evoked potential manifestations inWilson's disease with cerebral white matter involvement , 1989, Clinical Neurology and Neurosurgery.

[41]  P. Satishchandra,et al.  Visual and brain stem auditory evoked responses in Wilson's disease , 1989, Acta neurologica Scandinavica.

[42]  N. Chu Motor evoked potentials in Wilson's disease: early and late motor responses , 1990, Journal of the Neurological Sciences.

[43]  R. Shakir,et al.  Brainstem auditory evoked potentials in Wilson's disease , 1990, Journal of the Neurological Sciences.

[44]  L. Prayer,et al.  Evoked potentials in assessment and follow-up of patients with Wilson's disease , 1990, The Lancet.

[45]  [Wilson's disease: computed tomography and magnetic resonance imaging]. , 1990, Neurologia.

[46]  N. Chu,et al.  EEG spectral analysis and topographic mapping in Wilson's disease , 1991, Journal of the Neurological Sciences.

[47]  C. Kirsch,et al.  SPECT imaging of dopamine D2 receptors with 123I‐IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease , 1991, Nuclear medicine communications.

[48]  K. Yoshikawa,et al.  Mid-brain pathology of Wilson's disease: MRI analysis of three cases. , 1991, Journal of Neurology Neurosurgery & Psychiatry.

[49]  A. Young,et al.  Initial therapy of patients with Wilson's disease with tetrathiomolybdate. , 1991, Archives of neurology.

[50]  H. Imhof,et al.  Comparison of functional and structural brain disturbances in Wilson's disease , 1991, Neurology.

[51]  C. Madl,et al.  Detailed evaluation of evoked potentials in Wilson's disease. , 1992, Electroencephalography and clinical neurophysiology.

[52]  T. Vogl,et al.  Decrease of D2 receptors indicated by 123I‐iodobenzamide single‐photon emission computed tomography relates to neurological deficit in treated Wilson's disease , 1992, Annals of neurology.

[53]  A. Beydoun,et al.  Correlation of evoked potential and MRI findings in Wilson's disease , 1993, Neurology.

[54]  E. Barbosa,et al.  Wilson's disease: magnetic resonance imaging (MRI) with clinical correlations in 16 cases. , 1993, Revista paulista de medicina.

[55]  H. Hefter,et al.  The diagnostic value of multi-modality evoked potentials in Wilson's disease. , 1994, Electromyography and clinical neurophysiology.

[56]  T. Vogl,et al.  Treatment with D‐penicillamine improves dopamine D2‐receptor binding and T2‐signal intensity in de novo Wilson's disease , 1994, Neurology.

[57]  H. Hefter,et al.  Motor impairment in Wilson's disease 3: the clinical impact of pyramidal tract involvement , 1994, Acta neurologica Scandinavica.

[58]  K. Kendler,et al.  An analysis of the clinical features of familial schizophrenia , 1994, Acta psychiatrica Scandinavica.

[59]  J. Heckmann,et al.  Wilson's disease: neurological and magnetic resonance imaging improvement on zinc treatment. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[60]  J. Roh,et al.  Initial and follow‐up brain MRI findings and correlation with the clinical course in Wilson's disease , 1994, Neurology.

[61]  Recurrent pulmonary embolism and chronic multivessel thrombophlebitis associated with a right-to-left shunt in the antiphospholipid syndrome. , 1995, Clinical nuclear medicine.

[62]  G. Jansen,et al.  Cranial MR in Wilson disease: abnormal white matter in extrapyramidal and pyramidal tracts. , 1995, AJNR. American journal of neuroradiology.

[63]  Initial clinical experiences with dopamine D2 receptor imaging by means of 2′-iodospiperone and single-photon emission computed tomography , 1995, Annals of nuclear medicine.

[64]  O. Pogarell,et al.  Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's diseas , 1995, Journal of neural transmission. Supplementum.

[65]  Brain SPECT in Wilson's disease. , 1995, Clinical nuclear medicine.

[66]  Motor cortex threshold in Wilson's disease (transcranial magnetic stimulation). , 1996, Neurologia i neurochirurgia polska.

[67]  Y. Shinohara,et al.  Reversible Magnetic Resonance Imaging Lesions in Wilson's Disease: Clinical‐Anatomical Correlation , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[68]  I. Wilkinson,et al.  Cranial MR imaging in Wilson's disease. , 1996, AJR. American journal of roentgenology.

[69]  B S Polla,et al.  Cellular basis of ECD brain retention. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[70]  N. Chu,et al.  Wilson's disease: resolution of MRI lesions following long‐term oral zinc therapy , 1996, Acta neurologica Scandinavica.

[71]  W. Takahashi,et al.  A Wilson's disease patient with prominent cerebral white matter lesions: five-year follow-up by MRI. , 1996, European neurology.

[72]  D. Slosman,et al.  Cellular Basis of BCD Brain Retention , 1996 .

[73]  D. Lee,et al.  Dopamine transporter imaging with [123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[74]  Y. Kuo,et al.  MRI Manifestations of Wilson's Disease and its Change in Response to Treatment , 1998 .